Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Foundation for Research in Genetics and Endocrinology, |
RCV000767859 | SCV000897702 | pathogenic | Tyrosinase-negative oculocutaneous albinism | 2019-02-27 | criteria provided, single submitter | clinical testing | The observed variant NM_000372.4:c.1110G>A (M370I) is a de novo missense variation found in exon 3 of the TYR gene. It has been reported in the gnomAD database with an allele frequency of 0.00000407. The in silico prediction of this variant is disease causing by MutationTaster2. The proband's parents are heterozygous carriers of the following mutations in the TYR gene: c.1147G>A (p.Asp383Asn) in exon 3 and c.1217C>T (p.pro406leu) in exon 4, both mutations are in cis. Furthermore, the variant c.1110G>A is not observed in both parents. Thus the proband has the parent's mutations in trans with the said variant : c.1110G>A. In summary, the variant meets the ACMG criteria to be classified as likely pathogenic based upon the evidence stated above. |
Fulgent Genetics, |
RCV005012292 | SCV005631373 | likely pathogenic | Tyrosinase-negative oculocutaneous albinism; Oculocutaneous albinism type 1B; SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2024-04-15 | criteria provided, single submitter | clinical testing |